KATIE LIVINGSTON: Open Payments
NPI 1841662483 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,802 in 98 payments from 20 companies in 2025. Trend: 2023 $1,712 · 2024 $2,082 · 2025 $1,802
Food & beverage: $1,802
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 45 | $641 |
| QOL Medical, LLC | 10 | $297 |
| Regeneron Healthcare Solutions, Inc. | 7 | $173 |
| Ardelyx, Inc. | 6 | $110 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $74 |
| Janssen Biotech, Inc. | 4 | $70 |
| Madrigal Pharmaceuticals | 3 | $61 |
| GENZYME CORPORATION | 2 | $61 |
| Daiichi Sankyo Inc. | 2 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $51 |
Products named: RINVOQ, Sucraid, DUPIXENT, MAVYRET, CREON, IBSRELA, XIFAXAN, TREMFYA.
Industry payments across SC — which companies pay providers there.
